Article
ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Mar 2011
Yin Ming, Yan Jingrong, Martinez-Balibrea Eva, Graziano Francesco, Lenz Heinz-Josef, Kim Hyo-Jin, Robert Jacques, Im Seock-Ah, Wang Wei-Shu, Etienne-Grimaldi Marie-Christine, Wei Qingyi
Abstract excerpt
PURPOSE: Nucleotide excision repair (NER) modulates platinum-based chemotherapeutic efficacy by removing drug-produced DNA damage. To summarize published data on the association between polymorphisms of NER genes (ERCC1 and ERCC2) and responses to oxaliplatin-based chemotherapies, we carried out...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
